GlaxoSmithKline is close to agreeing to a US$14.25 per share takeover of US biopharma company Human Genome Sciences. The US$3bn deal is to be made public today, 16 July, according…
GSK likely to takeover Human Genome Sciences
Would you like to read this article?
Register below to continue reading this article.
You will be able to read 2 articles. No payment details required.
You will also receive our daily M&A insights email.
There is no obligation to subscribe to the service but we hope that after the trialing your firm will decide to subscribe.
For details of subscription packages or if you are considering a subscription and would like to read a few more articles on your trial, please contact us at firstname.lastname@example.org and we will call you to discuss.
Already a subscriber? Login here